Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,678,707
+$256,739 QoQ
Shares Held
10,645
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,732
of 4,153 holders
Holding Since
Sep 2024
8 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kestra Investment Management, LLC holds $21,637,945 across 10 Drug Manufacturers - General names. ABBV ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,960 | $5,323,211 | |
| 2 | LLY |
ELI LILLY & Co
|
2,418 | $2,900,221 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,645 | $2,678,707 | |
| 4 | PFE |
Pfizer Inc
|
108,921 | $2,622,817 | |
| 5 | AMGN |
Amgen Inc
|
6,708 | $2,429,100 | |
| 6 | MRK |
Merck & Co., Inc.
|
16,464 | $2,115,624 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,429 | $1,868,558 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,983 | $1,134,912 |
All Filings in ABBV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,678,707 | 10,645 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,421,968 | 11,136 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,398,130 | 6,119 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,436,242 | 6,203 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,739,073 | 9,369 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,541,438 | 7,357 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,263,091 | 7,108 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,091,866 | 5,529 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||